Search Filters

Search Results

Found 1 results

510(k) Data Aggregation

    K Number
    K153513
    Date Cleared
    2016-03-04

    (88 days)

    Product Code
    Regulation Number
    884.1730
    Reference & Predicate Devices
    Predicate For
    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The device Insufflator 50L FM134 is a CO2 insufflator intended for use during diagnostic and/or therapeutic endoscopic procedures to distend a cavity by filling it with gas. The Standard, Pediatric and Bariatric operating modes of the device are indicated to fill and distend a peritoneal cavity with gas during a laparoscopic procedure. The Pediatric operating mode is specifically indicated for pediatric laparoscopic procedures. The Vessel Harvesting operating mode is indicated for use during endoscopic vessel harvesting procedures to create a cavity along the saphenous vein or radial artery.

    Device Description

    The Insufflator 50L FM134 is a microprocessor controlled CO2 insufflator that consists of the following major components and features: a casing, a world power supply, pressure reducers, a venting system, redundant pressure measurement, a fluid sensor, a gas heater, a software controlled graphical user interface (GUI) touch screen and various setting keys and display elements. The Insufflator 50L FM134 is not intended to enter the sterile field, and cannot be sterilized. The device is to be used with specially designed single-use tube sets that are delivered sterile. Specifically, the proposed device is to be used with a single-use tube set with heating wire and integrated filter or with a single-use tube set with integrated filter but without heating wire.

    AI/ML Overview

    The provided text describes the 510(k) premarket notification for the Insufflator 50L FM134. However, it does not detail specific acceptance criteria or an overarching study proving the device meets acceptance criteria in the way one might expect for a diagnostic or prognostic AI/ML device (e.g., sensitivity, specificity, AUC thresholds).

    Instead, the document focuses on demonstrating substantial equivalence to predicate devices through various tests and comparisons. The "acceptance criteria" can be inferred from the standards and comparisons performed.

    Here's a breakdown based on the provided text, addressing the points where information is available and noting where it is not:

    1. Table of Acceptance Criteria and Reported Device Performance

    Since this is a medical device (CO2 insufflator) and not an AI/ML diagnostic, the acceptance criteria are not in terms of traditional metrics like sensitivity/specificity but rather compliance with safety, performance, and biocompatibility standards, and comparability to predicate devices.

    Acceptance Criterion (Inferred from tests performed)Reported Device Performance (Summary from study)
    Electrical Safety (IEC 60601-1:2005)- Conforms to the standard.
    Electromagnetic Compatibility (IEC 60601-1-2:2007)- Conforms to the standard.
    Software Development & Verification- Developed, tested, and verified in accordance with "Software Contained in Medical Devices" guidance and IEC 62304:2006. - Design verification demonstrates the device performs as intended and does not raise new questions of safety and effectiveness.
    Comparative Bench Testing (vs. 45L Core Insufflator F114)- Reaching set pressure: Comparable to predicate. - Compensation of small and large leakages: Comparable to predicate. - Overpressure scenarios: Comparable to predicate. - Maximum flow rate (50 l/min vs. 45 l/min): Leads on average to a slightly better insufflation performance compared to the predicate device 45L Core Insufflator. Also substantially equivalent to Nebulae™ I 50 LPM Insufflator for this characteristic.
    Biocompatibility (ISO 10993 series)- Cytotoxicity: Conforms to ISO 10993-5:2009. - Irritation and Skin Sensitization: Conforms to ISO 10993-10:2010. - Systemic Toxicity: Conforms to ISO 10993-11:2006. - Chemical Characterization (for heated tube set): Conforms to ISO 10993 - 18:2005.
    ETO Sterilization Validation (Tube Sets)- EO & ECH Residuals: Limit of EO < 4 mg and ECH < 5 mg (after 10 days aeration) not exceeded. - Sterility Assurance Level (SAL): < 10^-6. - Conforms to: ISO 11135-1:2007, ISO 14937:2009, ISO 10993-7:2008, AAMI TIR 28:2009.
    Package & Product Integrity (Tube Sets)- Conforms to ISO 11607-1 and ASTM-F-1980:2002.

    2. Sample Size for the Test Set and Data Provenance

    • Sample Size: The document does not specify a "sample size" in terms of patient data or case numbers for the performance tests. The tests performed are primarily laboratory-based bench tests (e.g., electrical safety, EMC, software verification, comparative performance of insufflation characteristics, biocompatibility of materials, sterilization validation).
    • Data Provenance: The tests were performed by "independent laboratories" (for electrical safety and EMC) and implicitly by the manufacturer or their designated testing facilities for others. The nature of the device (insufflator) means there wouldn't typically be "country of origin of the data" in the sense of clinical patient data, nor is it described as retrospective or prospective.

    3. Number of Experts Used to Establish Ground Truth and Qualifications

    This information is not applicable and not provided. The "ground truth" for this device's evaluation is based on established engineering standards, physical performance measurements, and biological compatibility standards, rather than expert interpretation of medical images or clinical outcomes.

    4. Adjudication Method for the Test Set

    This is not applicable and not provided. Adjudication methods like 2+1 or 3+1 are typically used for establishing ground truth in clinical evaluations where there might be disagreement among experts. The tests performed for this insufflator are objective measurements against predefined standards.

    5. Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study

    • Was it done?: No. An MRMC study is not relevant for this type of medical device (an insufflator). This type of study is typically performed for AI/ML diagnostic tools where human readers (e.g., radiologists) interpret images with and without AI assistance.
    • Effect size of human readers improvement with AI vs. without AI assistance: Not applicable.

    6. Standalone Performance

    • Was it done?: Yes, to the extent that an insufflator operates as a standalone device. The device's performance (e.g., flow rate, pressure regulation, leakage compensation) was tested independently against specifications and compared to predicate devices in bench testing. There is no "human-in-the-loop" performance as the device directly performs its function (insufflation).

    7. Type of Ground Truth Used

    The "ground truth" for the tests described is based on a combination of:

    • International Standards: e.g., IEC 60601-1, IEC 60601-1-2, IEC 62304, ISO 10993 series, ISO 11135-1, ISO 14937, ISO 11607-1, ASTM-F-1980.
    • Predicate Device Performance: The characteristics of the legally marketed predicate devices (45L Core Insufflator F114 and Nebulae™ I 50 LPM Insufflator) served as a benchmark for comparison to demonstrate substantial equivalence.

    8. Sample Size for the Training Set

    This information is not applicable and not provided. This device is an electro-mechanical insufflator, not an AI/ML system that requires a "training set."

    9. How the Ground Truth for the Training Set Was Established

    This information is not applicable.

    Ask a Question

    Ask a specific question about this device

    Page 1 of 1